Haleon to invest $54 million in US R&D centre to boost product innovation
Published by Global Banking & Finance Review®
Posted on January 29, 2025
1 min readLast updated: January 27, 2026

Published by Global Banking & Finance Review®
Posted on January 29, 2025
1 min readLast updated: January 27, 2026

Haleon is investing $54 million in its Richmond, US R&D center to enhance product innovation, complementing its significant annual R&D spending.
(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
The company said the investment is in addition to its 300 million pound ($372.5 million) annual spending in R&D.
The Richmond facility is one of the three R&D centres of excellence for Haleon, along with Weybridge, UK and Suzhou, China.
($1 = 0.8053 pounds)
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Arun Koyyur)
Haleon is investing $54 million in its global research and development center in Richmond, U.S.
The investment is in addition to Haleon's annual spending of 300 million pounds, which is approximately $372.5 million.
Haleon has three R&D centers of excellence located in Richmond, US; Weybridge, UK; and Suzhou, China.
Explore more articles in the Finance category


